The fight to protect children from irreversible medical procedures just gained a powerful new tool. Under President Trump, the Department of Health and Human Services (HHS) has established a critical whistleblower tip line aimed squarely at stopping the chemical and surgical sex changes being performed on minors.
This action directly enforces the President’s executive order, “Protecting Children From Chemical and Surgical Mutilation.” Concerned citizens, healthcare workers, and others now have a dedicated, official channel to report the administration of puberty blockers, cross-sex hormones, or sex change surgeries on children.
Standing Up for Whistleblowers and Religious Freedom
HHS isn’t just asking for reports; it’s promising protection for those brave enough to speak out. The department has clearly stated its commitment “to protecting whistleblowers to the full extent of the law.”
This promise is already being put into action. HHS recently launched a probe into a major children’s hospital, investigating allegations that it fired a nurse for exercising her federally protected conscience rights. The nurse reportedly requested a religious accommodation, refusing to administer puberty blockers and cross-sex hormones due to her deeply held beliefs about the sterilizing impact of these interventions on children.
Many believe the nurse involved is Vanessa Sivadge, formerly of Texas Children’s Hospital, who courageously testified before Congress this week about her experience.
Anthony Archeval, the Acting HHS OCR Director, affirmed the department’s resolve: “The Department will robustly enforce Federal laws protecting these courageous whistleblowers, including laws that protect health care professionals from being forced to violate their religious beliefs or moral convictions.”
Your Voice Matters: Report Concerns Now
This initiative provides a vital avenue for safeguarding children. If you have information about chemical or surgical interventions being performed on minors in violation of these protections, HHS encourages you to use the new system.
To learn more or to submit a confidential tip or complaint, visit the official HHS page:
This tip line represents a significant step in shielding vulnerable children from procedures the administration views as harmful and inappropriate for minors.
Methylene Blue, also known by its chemical name methylthioninium chloride and commonly referred to as Swiss Blue, is a versatile compound with a rich history spanning over a century. Initially synthesized in 1876 by the German chemist Heinrich Caro, its primary application was as an aniline-based dye within the textile industry. The subsequent discovery of its unique properties led to its adoption in various scientific and medical fields, marking it as the “first fully synthetic drug used in medicine”. This report aims to provide a comprehensive overview of Methylene Blue, encompassing its chemical identity, fundamental properties, historical and current medical uses, ongoing scientific research into potential future applications, its diverse non-medical uses, potential health benefits that are still under investigation, the known risks and side effects associated with its use, and its legal and regulatory status within the United States.
2. Chemical Identity and Fundamental Properties
2.1 Chemical Formula and Nomenclature
The chemical formula for Methylene Blue is It is important to note that Methylene Blue can also exist in a hydrated form, which contains three molecules of water per unit of the compound. The International Union of Pure and Applied Chemistry (IUPAC) name for Methylene Blue is [7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride. Beyond these formal designations, Methylene Blue is known by a variety of other common names and synonyms, including Methylthioninium chloride, Swiss Blue, Basic Blue 9, CI 52015, Urelene blue, Provayblue, Proveblue, and Methylenium ceruleum. Chemically, Methylene Blue is classified as a formal derivative of phenothiazine and belongs to the thiazine dye family. The existence of multiple names and the distinction between anhydrous and hydrated forms underscore the necessity for precision when referring to or utilizing this compound in both research and clinical settings. Subtle differences in these forms, such as solubility and stability, can influence its behavior and efficacy.
2.2 Molecular Weight and Structure
The molar mass of anhydrous Methylene Blue is approximately 319.85 g/mol, while the trihydrate form has a molar mass of 373.9 g/mol. The molecular structure of Methylene Blue is characterized by three interconnected cyclic structures. A central phenothiazine ring system is linked to sulfur and nitrogen atoms, featuring dimethylamino groups at positions 3 and 7. The molecule carries a positive charge on a nitrogen atom, which is balanced by a chloride counterion. This structural arrangement classifies Methylene Blue as a cationic heterocyclic compound. A key feature of Methylene Blue is its redox activity, which allows it to exist in two primary forms: an oxidized state, which is blue in color, and a reduced state, known as leuco-methylene blue, which is colorless. This ability to readily accept and donate electrons is fundamental to many of its biological activities, including its established use in treating methemoglobinemia and its potential role in influencing mitochondrial function.
2.3 Physical and Chemical Properties
At room temperature, Methylene Blue presents as a dark green crystalline powder, often exhibiting a bronze-like luster. When dissolved in polar solvents such as water or alcohol, it yields a characteristic deep blue solution. Its solubility varies across different solvents: it is readily soluble in water, glycerol, chloroform, glacial acetic acid, and ethanol; slightly soluble in pyridine; and practically insoluble in ethyl ether, oleic acid, and xylene. The specific solubility in water is reported to be around 4.36 g per 100 mL at 25°C. Notably, the solubility in solvents like DMSO and ethanol can be enhanced at elevated temperatures. The melting point of Methylene Blue is in the range of 100 to 110 °C, at which point it also begins to decompose , although some sources indicate a decomposition temperature closer to 180°C. When dissolved in water, Methylene Blue exhibits slightly acidic properties , with a 1% aqueous solution having a pH of approximately 6. The compound absorbs light maximally in the region of 664 to 670 nm. While generally stable under normal conditions, Methylene Blue is sensitive to light, which can lead to its degradation. The solubility profile of Methylene Blue is a critical factor influencing its administration and distribution within biological systems. Its light sensitivity has implications for its use in photodynamic therapy and necessitates careful storage to maintain its potency [Chain of thought: How it dissolves affects how it can be formulated (e.g., for injection vs. oral). Light degradation could impact the potency of stored solutions.].
Table 1: Chemical and Physical Properties of Methylene Blue
Methylthioninium chloride, Swiss Blue, Basic Blue 9, CI 52015, etc.
Molecular Weight (Anhydrous)
319.85 g/mol
Molecular Weight (Trihydrate)
373.9 g/mol
Appearance
Dark green crystalline powder with a bronze-like luster
Solubility in Water
4.36 g/100 mL at 25°C
Solubility in Other Solvents
Soluble in glycerol, chloroform, glacial acetic acid, ethanol; slightly soluble in pyridine; insoluble in ethyl ether, oleic acid, xylene
Melting Point
100 to 110 °C (decomposes)
Maximum Absorption Wavelength
664-670 nm
3. A Historical Perspective on Methylene Blue in Medicine
3.1 Early Discoveries and Applications
The journey of Methylene Blue from a textile dye to a significant medical agent began with its recognition as a valuable biological stain. In 1880, Robert Koch, a pioneer in microbiology, established its utility as a stain in medical applications, a finding corroborated and expanded upon by Paul Ehrlich. Ehrlich, in the 1890s, made a groundbreaking observation: Methylene Blue exhibited effectiveness against malaria parasites in human blood, marking it as the first fully synthetic drug to be successfully used in treating human illnesses. This discovery aligned with Ehrlich’s “magic bullet” theory, which posited that specific chemicals could selectively target and harm pathogens without damaging surrounding tissues, a revolutionary concept that laid the foundation for modern chemotherapy. During World War I, Methylene Blue also found application as an antiseptic for treating wounds, demonstrating its antimicrobial properties. It was, in fact, the first synthetic antiseptic to be used therapeutically. Historically, it was also employed in the treatment of gonorrhea and fever. These early applications highlight the initial promise and versatility of Methylene Blue in addressing various medical challenges.
3.2 Treatment of Methemoglobinemia
A significant milestone in the medical history of Methylene Blue occurred in 1933 when it was discovered to be an effective antidote for aniline-induced methemoglobinemia by Williams and Challis. Methemoglobinemia is a condition characterized by an elevated level of methemoglobin in the blood, a form of hemoglobin that cannot effectively carry oxygen to the body’s tissues. Methylene Blue works by chemically reducing the ferric iron (Fesup3+/sup) present in methemoglobin back to the ferrous iron (Fesup2+/sup) state in hemoglobin, thereby restoring the blood’s oxygen-carrying capacity. This mechanism has established Methylene Blue as a crucial treatment for acquired methemoglobinemia, which can be caused by exposure to certain pharmaceuticals, toxins, or even broad beans in susceptible individuals. The effectiveness of Methylene Blue in this context is a testament to its direct and specific biochemical action on hemoglobin.
3.3 Other Historical Uses
Beyond its roles in malaria treatment and methemoglobinemia, Methylene Blue has been explored for various other medical applications throughout history. It was once considered a weak antimalarial agent, but its use diminished with the advent of more potent drugs like chloroquine. However, the increasing prevalence of drug-resistant malaria has led to a renewed interest in Methylene Blue as a potential component of antimalarial treatment regimens. Similarly, Methylene Blue was historically recommended as an intestinal and urinary antiseptic, although this use is no longer prevalent. Nevertheless, some sources still mention its application in treating urinary tract infections. In 1933, Matilda Brooks discovered its potential as an antidote for both cyanide and carbon monoxide poisoning , although it is no longer the primary treatment for cyanide poisoning. Notably, Methylene Blue was also one of the first drugs used in the late 19th century for the treatment of patients with psychosis and played a role in the serendipitous development of phenothiazine antipsychotic drugs in the mid-20th century. The varied trajectory of Methylene Blue’s medical applications reflects the continuous advancements in pharmacological science and the development of more targeted therapies. The resurgence of interest in its antimalarial properties highlights the ongoing challenges posed by drug resistance.
4. Current FDA-Approved Medical Applications of Methylene Blue
4.1 Treatment of Acquired Methemoglobinemia
The primary FDA-approved medical application of Methylene Blue is the treatment of acquired methemoglobinemia in both pediatric and adult patients. This approval underscores the established efficacy and safety of Methylene Blue for this specific condition. Several intravenous formulations are available, including ProvayBlue, which was the first methylene blue injection to receive FDA approval. Generic versions of methylene blue injection have also been approved by the FDA, enhancing the accessibility of this essential medication. The typical intravenous dosage for treating methemoglobinemia is 1 mg/kg of a 1% solution, administered slowly over a period of 5 to 30 minutes. If methemoglobin levels remain elevated or clinical signs persist, a repeat dose may be administered one hour after the initial dose. The FDA approval of Methylene Blue for methemoglobinemia signifies a robust body of evidence supporting its benefit in this critical medical situation.
4.2 Diagnostic Aid
Methylene Blue is also FDA-approved for various diagnostic purposes, leveraging its staining properties to enhance visualization during medical procedures. One significant application is in sentinel lymph node mapping, a crucial technique used during breast surgery and other cancer surgeries to identify the lymph nodes most likely to contain cancerous cells. In this procedure, a typical dose of 2 mL or 5 mL of a 1% methylene blue solution is injected into the tissue near the tumor, allowing surgeons to visually trace the lymphatic drainage. Furthermore, Methylene Blue is employed as a dye in chromoendoscopy, where it is sprayed onto the mucosa of the gastrointestinal tract to aid in the identification of dysplasia, or pre-cancerous lesions. It is also utilized in endoscopic polypectomy as an adjunct to saline or epinephrine injection. Another diagnostic application involves the intravenous administration of Methylene Blue to assist in the identification of parathyroid glands during surgery. The dye stains the glands, making them easier for surgeons to locate. A typical dose for this purpose is 5 mg/mL given approximately one hour before the surgical procedure. Additionally, because intravenously injected Methylene Blue is readily excreted in the urine, it can be used to test for leaks or fistulas within the urinary tract. These diagnostic uses highlight the value of Methylene Blue’s staining properties in improving the precision and effectiveness of various medical and surgical procedures.
4.3 Combination Drug for Urinary Tract Issues
Methylene Blue is also a component of several FDA-approved combination drugs, such as Hyophen, Methylphen, Urophen, and Urised. These medications are indicated for the symptomatic treatment of pain, burning, urgency, and frequency associated with cystitis, urethritis, and other urinary tract disorders. In these formulations, Methylene Blue is combined with other active ingredients like hyoscyamine, hexamethylenetetramine, phenyl salicylate, and benzoic acid. While Methylene Blue has a history of use as a mild urinary antiseptic, its current approved application in this context is within these multi-component drugs, suggesting a synergistic or complementary role in alleviating urinary tract symptoms.
Table 2: Current FDA-Approved Medical Applications of Methylene Blue
Indication
Route of Administration
Typical Dosage
Specific FDA Approval Details
Acquired Methemoglobinemia
Intravenous
1 mg/kg of a 1% solution over 5-30 minutes, repeat dose if needed
ProvayBlue (first approved brand), generic versions available
Sentinel Lymph Node Mapping
Intraparenchymal
2 mL or 5 mL of a 1% solution injected near the tumor
Used in breast surgery and other cancer surgeries
Visualization in Endoscopic Procedures
Topical (spray/injection)
Varies depending on the procedure
Chromoendoscopy for dysplasia detection, endoscopic polypectomy
Parathyroid Gland Identification
Intravenous
5 mg/mL one hour before the procedure
Aids in locating parathyroid glands during surgery
Urinary Tract Leak Detection
Intravenous
Dosage not specified
Excreted in urine to detect leaks or fistulas
Symptomatic Treatment of Urinary Tract Pain
Oral (in combination drugs)
Dosage determined by the specific combination product
Component of drugs like Hyophen, Methylphen, Urophen, Urised, which also contain hyoscyamine, hexamethylenetetramine, phenyl salicylate, and benzoic acid
Export to Sheets
5. Ongoing Scientific Studies and Potential Future Medical Uses of Methylene Blue
5.1 Neurodegenerative Disorders
Methylene Blue has garnered significant attention for its potential in treating various neurodegenerative disorders. Extensive research is underway to explore its effects on Alzheimer’s disease, with studies investigating its ability to inhibit the aggregation of tau proteins and reduce the formation of amyloid-beta plaques, both hallmarks of the disease. Some clinical trials, particularly those involving modified forms of Methylene Blue like LMTX (leuco-methylthioninium bis(hydromethanesulfonate)), have shown promising results in specific subgroups of patients. Lower doses of Methylene Blue have also been associated with enhanced cognitive function in some studies. However, it is important to note that several large-scale phase 3 clinical trials have not met their primary endpoints, indicating the need for further investigation to optimize dosing, formulations, and identify the patient populations that might benefit most. Preclinical studies also suggest that Methylene Blue may have neuroprotective effects in Parkinson’s disease by reducing oxidative stress and protecting dopaminergic neurons. Furthermore, its potential is being explored in other neuropsychiatric disorders, including bipolar disorder, claustrophobia, ifosfamide encephalopathy, and schizophrenia , as well as autism, depression, neurodegenerative diseases, and traumatic brain injury. A completed clinical trial indicates that intraoperative use of Methylene Blue may reduce postoperative delirium and cognitive dysfunction in elderly patients undergoing major noncardiac surgery. The ability of Methylene Blue to cross the blood-brain barrier and its potential to enhance mitochondrial function and act as an antioxidant are key reasons for its investigation in these neurological conditions [Chain of thought: While preclinical data is promising, translating these findings to consistent clinical benefits in complex neurodegenerative diseases is challenging and requires rigorous investigation.].
5.2 Cancer Therapy
The role of Methylene Blue in cancer therapy is also an active area of research. Its potential in photodynamic therapy (PDT) is being explored as a means to selectively kill cancer cells. Preclinical studies have shown its effectiveness against various cancer types, including colorectal tumors, carcinoma, and melanoma , although results have been less promising in breast cancer and HeLa cell models. Clinical trials are investigating its efficacy in treating pain associated with oral mucositis in cancer patients. Researchers are also examining its potential to enhance the effectiveness of radiation therapy, particularly in making hypoxic tumor cells more susceptible to radiation. In animal models, Methylene Blue has shown promise as a metabolic therapy in restraining ovarian tumor growth. Additionally, its use in facilitating the evaluation of lymph nodes in colon cancer specimens is being studied. The photosensitizing properties of Methylene Blue, activated by light to produce cytotoxic singlet oxygen, and its potential to interfere with cancer cell metabolism are the basis for these investigations.
5.3 Infectious Diseases
There is a renewed interest in Methylene Blue as an antimalarial agent, particularly in the face of increasing resistance to existing drugs. Studies are exploring its effectiveness against drug-resistant strains of malaria and its ability to prevent transmission by targeting the gametocyte stage of the parasite. Methylene Blue is also being investigated for its broad-spectrum antiviral activity, with potential applications against respiratory viral infections such as influenza and SARS-CoV-2. Experimental studies have demonstrated its inhibitory effects on viral replication. Its antimicrobial properties are also being researched in the context of treating bacterial infections, including urinary tract infections, and as a general disinfectant. Notably, laboratory studies suggest its effectiveness against persister biofilms, which are relevant to chronic infections like Lyme disease and Bartonella. Furthermore, Methylene Blue is used in some settings for decontaminating blood plasma products due to its antiviral and antibacterial properties. The diverse antimicrobial and antiviral activities of Methylene Blue, combined with its relatively low toxicity and cost, make it a promising candidate for addressing infectious diseases, especially in resource-limited settings and against emerging pathogens.
5.4 Septic Shock and Vasoplegic Syndrome
Methylene Blue is under investigation for its potential to treat refractory hypotension in septic shock. Its mechanism of action involves inhibiting nitric oxide synthase and guanylate cyclase, which can help restore vascular tone. Clinical trials are currently ongoing to further evaluate its safety and efficacy in this context. Additionally, Methylene Blue is used off-label to increase blood pressure in individuals experiencing vasoplegic syndrome, a condition often occurring after cardiac surgery where blood pressure drops dangerously low and does not respond to standard treatments like epinephrine. Some studies suggest that early administration of Methylene Blue in patients with vasoplegic syndrome may improve survival rates. The ability of Methylene Blue to modulate nitric oxide pathways, which play a critical role in vasodilation, makes it a potential therapeutic option for managing these severe conditions.
Table 3: Potential Future Medical Uses of Methylene Blue Under Investigation
Medical Condition
Proposed Mechanism of Action
Current Status of Research
Key Findings/Outcomes (if available)
Alzheimer’s Disease
Inhibits tau aggregation, reduces amyloid-beta plaques, enhances mitochondrial function
Preclinical and Clinical Trials (Phase 2/3)
Mixed results in clinical trials, some promise in subgroups with modified forms and lower doses
Demonstrates antiviral activity in laboratory settings
Bacterial Infections (e.g., Lyme, Bartonella)
Antimicrobial, effective against persister biofilms
Preclinical and Anecdotal Reports
Shows promise in laboratory studies and some clinical observations
Septic Shock
Inhibits nitric oxide synthase and guanylate cyclase, restores vascular tone
Clinical Trials (Phase 2/3)
Some studies show improved hemodynamic parameters and reduced vasopressor requirements
Vasoplegic Syndrome
Inhibits nitric oxide synthase and guanylate cyclase, restores vascular tone
Off-label use, Retrospective and Prospective Studies
Early administration may improve survival after cardiac surgery
Export to Sheets
6. Explore Non-Medical Applications of Methylene Blue
6.1 Use in Aquariums
Methylene Blue finds application in the maintenance of aquariums, primarily as a disinfectant. It is commonly used to treat fungal infections that can affect fish and their eggs, as well as parasitic diseases such as ich (Ichthyophthirius multifiliis). Additionally, it can be effective against certain bacterial infections in fish. Beyond treating existing conditions, Methylene Blue can also aid in mitigating the toxicity caused by elevated levels of ammonia and nitrites in aquarium water, which can be harmful to aquatic life. Its antimicrobial properties, therefore, extend beyond medical contexts to play a role in maintaining the health and well-being of fish in aquariums.
6.2 Dye in Textiles and Microscopy
Historically, Methylene Blue was first synthesized for use as a dye in the textile industry, particularly for coloring cotton and wool fabrics. Its strong and lasting blue hue made it a valuable component in textile manufacturing. In the realm of science, Methylene Blue is a widely employed biological stain in microscopy. It is used to enhance the visibility of cells, tissues, and microorganisms under a microscope, often staining negatively charged cell components such as nucleic acids. It is a component of important stains used in hematology and microbiology, including Wright’s stain and Jenner’s stain. The fundamental staining properties of Methylene Blue were crucial to its early scientific and industrial applications, highlighting its inherent affinity for biological materials.
6.3 Redox Indicator in Chemistry
Methylene Blue is a well-known redox indicator in analytical chemistry. Solutions containing Methylene Blue will appear blue in the presence of an oxidizing environment. However, if exposed to a reducing agent, the solution will undergo a color change and become colorless as the Methylene Blue is reduced to its leuco form. This property is famously demonstrated in the “blue bottle” experiment, a classic demonstration of chemical kinetics. Methylene Blue is also utilized in sulfide analysis, where its reaction with hydrogen sulfide can be quantified. Additionally, it can function as an indicator for pH changes in certain applications. The reversible color change of Methylene Blue based on the redox state of its environment makes it a valuable tool for visualizing and studying chemical reactions involving electron transfer.
6.4 Photosensitizer
Methylene Blue acts as a photosensitizer, meaning it can absorb light and transfer energy to oxygen, converting it into singlet oxygen, a highly reactive form. This property is harnessed in photodynamic therapy (PDT), where Methylene Blue, in conjunction with light exposure, is used to destroy target cells, such as cancer cells or microorganisms. The same principle is applied in the disinfection of blood plasma, where light-activated Methylene Blue can effectively kill certain viruses and bacteria, enhancing the safety of blood transfusions. This interaction with light to generate reactive oxygen species is a key aspect of its potential in targeted therapeutic applications.
6.5 Other Uses
Beyond these primary non-medical applications, Methylene Blue has a variety of other uses. In the food industry, it is employed to test the freshness of milk and dairy products, where its reduction to a colorless form indicates low oxygen levels associated with spoilage. Its use in the textile industry for dyeing natural fibers like cotton, wool, and silk continues. In educational settings, Methylene Blue is a valuable tool for demonstrating redox reactions and chemical equilibrium, such as in the Blue Bottle Experiment, and for staining cells to facilitate microscopic observation by students. It also has applications in environmental science, where it can be used to demonstrate dissolved oxygen levels in water, illustrating concepts of water quality. In orthopedic surgery, Methylene Blue is sometimes added to bone cement to provide a visual distinction between the cement and native bone, and it can also accelerate the hardening process. Certain medical devices incorporate Methylene Blue as a visualization aid. Finally, it is used in construction and soil science to determine the methylene blue value of fine aggregate, an indicator of its clay mineral content. The sheer diversity of these non-medical applications underscores the multifaceted nature of Methylene Blue, stemming from its unique chemical and physical properties [Chain of thought: From industrial applications to educational demonstrations, its unique characteristics make it valuable in diverse fields.].
7. Identify Any Potential Health Benefits of Methylene Blue That Are Not Yet Fully Established or Approved by Regulatory Bodies
7.1 Cognitive Enhancement and Anti-Aging
Emerging research suggests that Methylene Blue may possess potential health benefits beyond its currently approved medical uses, particularly in the areas of cognitive enhancement and anti-aging. Some studies indicate that it may have cognitive-enhancing effects, potentially improving memory and attention span. Animal studies have shown that Methylene Blue can improve age-related memory decline and enhance grip strength and spatial memory in older mice. These effects may be linked to its ability to enhance mitochondrial function in brain cells, which is crucial for energy production and overall cognitive health. Furthermore, Methylene Blue exhibits antioxidant properties that could protect cells, including neurons, against damage from oxidative stress, a process implicated in aging. While these findings from preclinical studies and some early-phase clinical trials are promising, more rigorous and large-scale clinical trials in humans are necessary to definitively establish these benefits and determine safe and effective dosages. It is important to note that over-the-counter Methylene Blue products marketed for cognitive enhancement or anti-aging are not currently regulated by the FDA, and their safety and efficacy have not been fully evaluated .
7.2 Mental Health Support (Beyond Approved Uses)
Research is also exploring the potential of Methylene Blue in providing support for various mental health conditions beyond its historical use in psychosis. Some studies have investigated its use as an adjunct treatment for mood disorders such as depression and bipolar disorder. It is believed that Methylene Blue may influence the levels of certain neurotransmitters in the brain, including serotonin, norepinephrine, and acetylcholine, which play critical roles in mood regulation. Animal models have shown that Methylene Blue exhibits antidepressant-like activity. While these preliminary findings are encouraging, the use of Methylene Blue for mental health support is still considered investigational. Careful consideration of potential drug interactions, particularly with medications that affect serotonin levels, is essential due to Methylene Blue’s properties as a monoamine oxidase inhibitor .
7.3 Lyme Disease and Co-infections
Some practitioners, particularly Lyme Literate Medical Doctors (LLMDs), are exploring the off-label use of Methylene Blue for the treatment of Lyme disease and associated co-infections, such as Bartonella. Anecdotal reports suggest that patients treated with Methylene Blue have experienced improvements in symptoms like fatigue, depression, and cognitive fog, which are commonly associated with these tick-borne illnesses. Laboratory studies have indicated that Methylene Blue possesses antimicrobial properties and may be particularly effective against persister biofilms, a form of bacterial growth that can be difficult to eradicate in Lyme disease and Bartonella infections. However, it is crucial to emphasize that these uses are not yet fully established or approved by regulatory bodies. Rigorous clinical trials in humans are needed to determine the efficacy and safety of Methylene Blue for the treatment of Lyme disease and co-infections.
8. Research the Known Risks, Side Effects, and Contraindications Associated with the Use of Methylene Blue
8.1 Common Side Effects
The use of Methylene Blue is associated with several known side effects, the most common of which is a noticeable bluish-green discoloration of the urine and stool. Some individuals may experience pain in their limbs following intravenous administration. Gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain have also been reported. Other common side effects can include dizziness, confusion, and headaches , as well as staining of the mouth or teeth and an altered sense of taste. Some patients may also experience sweating , a burning sensation in the mouth and stomach , restlessness, apprehension, and an unusual taste sensation known as dysgeusia. It is important to note that Methylene Blue can transiently interfere with pulse oximeter readings, potentially leading to an underestimation of the actual oxygen saturation in the blood. Additionally, a decrease in the Bispectral Index (BIS), a measure of brain activity, has been observed following the administration of Methylene Blue during surgical procedures [Chain of thought: Many side effects are relatively mild and related to its properties as a dye and its biochemical actions. However, some can be more significant and require monitoring.].
8.2 Serious Risks and Contraindications
While many side effects are mild, Methylene Blue carries the risk of several serious adverse events and has specific contraindications. One of the most significant risks is the development of serotonin syndrome, a potentially life-threatening condition that can occur when Methylene Blue is used in combination with other drugs that increase serotonin levels in the brain, such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), opioids, and dextromethorphan. Symptoms of serotonin syndrome can include mental status changes, muscle twitching, excessive sweating, shivering, diarrhea, loss of coordination, and fever. Therefore, the concomitant use of Methylene Blue with serotonergic drugs should be avoided. Another serious risk is hemolytic anemia, which is more likely to occur in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. In these patients, Methylene Blue is contraindicated due to the risk of severe hemolysis , which can lead to the formation of Heinz bodies, elevated bilirubin levels, and low haptoglobin. Paradoxically, high doses of Methylene Blue can actually induce methemoglobinemia, the very condition it is used to treat. The administration of Methylene Blue in neonates carries significant risks, including hyperbilirubinemia, respiratory depression, pulmonary edema, phototoxicity, and hemolytic anemia. Methylene Blue is also contraindicated in patients with a known history of hypersensitivity or anaphylactic reactions to it. Its use is contraindicated during pregnancy (FDA pregnancy category X) due to the potential for fetal harm , and it should be avoided by breastfeeding women. Elderly patients with impaired kidney function may require dosage adjustments , and it is contraindicated in cases of severe renal insufficiency. Caution is also advised when using Methylene Blue in patients with hepatic impairment. Beyond serotonergic drugs, Methylene Blue can interact with other medications, including those metabolized by cytochrome P450 enzymes. As a monoamine oxidase inhibitor, it can interact with various substances. It should not be used concurrently with dapsone. Furthermore, if sodium nitrite is used as an antidote for cyanide poisoning, Methylene Blue should not be administered to treat the resulting methemoglobinemia, as this can reduce cyanide binding and increase toxicity .
Table 4: Known Risks, Side Effects, and Contraindications of Methylene Blue
Category
Specific Risk/Side Effect/Contraindication
Relevant Notes/Conditions
Common Side Effects
Bluish-green discoloration of urine and stool
Expected
Common Side Effects
Limb pain following IV administration
Common Side Effects
Nausea, vomiting, diarrhea, abdominal pain
Common Side Effects
Dizziness, confusion, headaches
Common Side Effects
Stained mouth or teeth
Common Side Effects
Altered sense of taste
Common Side Effects
Sweating
Common Side Effects
Burning sensation of the mouth and stomach
Common Side Effects
Restlessness, apprehension, dysgeusia
Common Side Effects
Transiently alters pulse oximeter readings
May underestimate oxygen saturation
Common Side Effects
Fall in Bispectral Index (BIS)
During surgery
Serious Risks
Serotonin Syndrome
With concomitant use of serotonergic drugs and opioids
Why is a targeted individual dating website is a good idea?
A targeted individual (TI) dating website could potentially offer a few benefits to individuals who identify as TIs:
Shared Experience and Understanding: Perhaps the most significant potential benefit is connecting with others who share similar experiences. The belief of being a TI can be incredibly isolating, and finding others who understand and validate those experiences could be validating and supportive. It could create a sense of community and reduce feelings of isolation.
Reduced Need for Explanation: Dating can be difficult for anyone, but explaining the complex and often misunderstood experiences associated with being a TI can be particularly challenging. A dedicated site could eliminate the need for constant explanations and potential skepticism from partners who don’t share those experiences. It could foster a sense of immediate understanding and acceptance.
Support Network: A dating site could potentially evolve into a broader support network, offering resources, information sharing, and a sense of solidarity among TIs. This could be invaluable for individuals navigating the challenges they face.
Safety in Numbers: Some TIs might feel safer connecting with others who understand the potential risks they perceive. There might be a sense of shared vigilance and mutual support.
It’s important to note that these are potential benefits. The actual success and value of such a site would depend on various factors, including its management, moderation, and the participation of the TI community.
The term “targeted individual dating” is not a recognized or widely used concept.
Targeted Individual (TI): This term refers to individuals who believe they are being subjected to surveillance, harassment, and other forms of covert psychological manipulation by government agencies or other powerful entities. Dating: Refers to the act of two people spending time together socially with the aim of assessing each other’s suitability as a romantic partner. Potential Interpretations:
Dating as a tactic: Some TIs might perceive dating as a potential avenue for their harassers to gather information, manipulate their emotions, or further their campaign of harassment. Difficulties in dating: The stress and trauma associated with being a TI can significantly impact an individual’s ability to form and maintain healthy relationships. This might include: Social isolation: Constant surveillance and harassment can make it difficult to meet people and engage in social activities. Distrust: TIs may find it challenging to trust potential partners due to their experiences with manipulation and deceit. Mental health challenges: The psychological impact of being a TI can lead to anxiety, depression, and other mental health issues that can interfere with dating. Important Note:
It’s crucial to approach the concept of “targeted individual dating” with caution. The experiences described by TIs are complex and often distressing. While some of their concerns may be valid, it’s essential to remember that many of the claims made by TIs lack concrete evidence and are often considered delusional by mental health professionals.
If you or someone you know is experiencing difficulties with dating due to mental health concerns, it’s important to seek professional help from a therapist or counselor.
Disclaimer: This information is for general knowledge and informational purposes only and does not constitute professional advice.
The concept of “gang stalking” is a serious and complex issue. Individuals who believe they are victims of gang stalking describe experiencing a coordinated and targeted campaign of harassment, surveillance, and psychological manipulation. They often report experiencing things like:
Constant surveillance: Being followed by groups of people, both in person and online.
Harassment and intimidation: Experiencing verbal abuse, pranks, and other forms of harassment.
Reputational attacks: Having rumors spread about them to damage their reputation and relationships.
Cyberstalking: Being harassed and monitored online.
Psychological manipulation: Experiencing tactics designed to cause emotional distress and instability.
It’s crucial to acknowledge that these experiences are incredibly real and distressing for the individuals who report them. The pain and suffering they describe are genuine. However, the causes and explanations for these experiences are highly debated.
Possible Explanations and Perspectives:
Mental health conditions: Some mental health conditions, such as paranoia or psychosis, can cause individuals to perceive threats and conspiracies that are not based in reality. This doesn’t diminish the individual’s suffering, but it points to the importance of mental health support.
Misinterpretation of events: Everyday occurrences might be misinterpreted as part of a targeted harassment campaign. For example, a stranger’s glance might be seen as part of a coordinated stalking effort.
Cognitive biases: Confirmation bias can lead individuals to focus on and interpret events in a way that confirms their belief that they are being targeted.
Lack of scientific evidence: There is no scientific evidence to support the existence of organized gang stalking campaigns as described by some individuals. Law enforcement agencies have also generally not found evidence to support these claims.
Important Considerations:
Real suffering: Regardless of the explanation, the distress and fear experienced by individuals who believe they are targeted are very real.
Stigma and isolation: These individuals often face stigma and disbelief, which can further isolate them and make it difficult to seek help.
Need for support: Individuals who believe they are targeted need support and understanding, even if the explanations for their experiences are debated.
If you or someone you know is experiencing these feelings:
Seek mental health support: Talking to a mental health professional can help individuals explore their experiences and develop coping strategies. This is crucial.
Connect with support groups: Online or in-person support groups can provide a sense of community and understanding, although it’s important to be aware that some online communities may reinforce beliefs without offering alternative perspectives or professional help.
Focus on well-being: Engaging in activities that promote physical and mental well-being can be helpful.
It’s vital to approach this topic with sensitivity and respect for the experiences of individuals who believe they are targeted. While the explanations for these experiences may be debated, the distress and need for support are very real. It’s also important to distinguish between offering support and unintentionally reinforcing potentially harmful beliefs. Encouraging individuals to seek professional mental health evaluation is often the most constructive approa
Skull to brain tech TI
The idea of “skull-to-brain tech” is often brought up in the context of Targeted Individuals (TIs) who believe they are being subjected to directed energy weapons or mind control technologies. They may report experiencing sensations like:
Artificial voices or thoughts being implanted in their minds.
Physical sensations like burning, tingling, or vibrations in their bodies.
Emotional manipulation or involuntary actions.
It’s important to acknowledge that these experiences are very real and distressing for the individuals who report them. However, the existence and nature of the technologies they describe are highly debated.
Scientific Perspective:
Lack of evidence: There is no scientific evidence to support the existence of technologies that can directly transmit voices or thoughts into someone’s brain or manipulate their physical actions from a distance.
Neurological explanations: Some neurological conditions or mental health issues can cause individuals to experience hallucinations or unusual physical sensations.
Misinterpretation of technology: Everyday technologies like cell phones or Wi-Fi signals might be misinterpreted as evidence of directed energy attacks.
TI Perspective:
Targeted harassment: TIs believe they are being targeted by covert organizations or individuals who are using these technologies to harass and control them.
Evidence gathering: Some TIs attempt to gather evidence of these attacks, such as recordings of unusual sounds or sensations, or medical tests to detect unusual implants.
Seeking solutions: TIs often seek information and support from each other, and some may explore legal or political avenues to address their concerns.
Important Considerations:
Real suffering: Regardless of the explanation, the distress and fear experienced by TIs are very real.
Need for support: TIs need support and understanding, even if the explanations for their experiences are debated.
Mental health support: Talking to a mental health professional can help individuals explore their experiences and develop coping strategies.
It’s crucial to approach this topic with sensitivity and respect for the experiences of individuals who believe they are targeted. While the existence of “skull-to-brain tech” as described by some TIs is not supported by scientific evidence, the distress and need for support are very real. It’s also important to distinguish between offering support and unintentionally reinforcing potentially harmful beliefs. Encouraging individuals to seek professional mental health evaluation is often the most constructive approach.
Havana Syndrome is a term used to describe a set of medical symptoms experienced by U.S. embassy staff and other government officials, primarily starting in Havana, Cuba in 2016.
Symptoms
Individuals affected by Havana Syndrome have reported a range of symptoms, including:
Auditory: Hearing a loud piercing sound or experiencing tinnitus (ringing in the ears)
Vestibular: Dizziness, vertigo, loss of balance, nausea
The cause of Havana Syndrome is still under investigation, and there is no definitive answer. Several theories have been proposed, including:
Sonic attack: The possibility of a directed energy weapon using sound waves to cause harm.
Microwave attack: Similar to a sonic attack, but using microwave radiation.
Pesticide exposure: The idea that exposure to pesticides or other environmental toxins could be responsible.
Psychogenic illness: A theory that the symptoms may be caused by psychological factors, such as stress or anxiety.
Investigation and Controversy
The U.S. government has launched multiple investigations into Havana Syndrome, but so far, no conclusive evidence has been found to support any specific cause. Some experts believe that the symptoms could be caused by a combination of factors, while others suggest that the cause may never be known.
The lack of a clear explanation has led to controversy and speculation, with some people suggesting that the U.S. government is covering up the truth. However, there is no evidence to support this claim.
Current Status
Havana Syndrome remains an ongoing issue, with new cases being reported in various locations around the world. The U.S. government continues to investigate the cause and provide medical care to affected individuals.
It’s important to note:
Havana Syndrome is a real and concerning medical issue.
The cause is still unknown and under investigation.
There is no definitive evidence to support any specific theory at this time.
If you or someone you know is experiencing symptoms that might be related to Havana Syndrome, it’s important to seek medical attention and report it to the appropriate authorities.
We have partnered with herbalife.com they are a global nutrition company that has
helped people pursue healthy, active lives
since 1980. Thier products are available
exclusively through Herbalife Members
and independent Distributors in more
than 90 countries.
Thier Products Our protein shakes and snacks,
vitamins and dietary supplements,
energy and fitness drinks, skin and hair
care products, combined with healthy
eating and exercise, can help you lead a
healthy, active life.
They also have a Proven Business Opportunity You can earn part-time income or pursue a
full-time business opportunity as an Herbalife
Independent Distributor.
Community Involvement We make a difference by providing good
nutrition to children through our Herbalife
Family Foundation Casa Herbalife programs.
Herbalife Members, independent Distributors
and employees play an active role in
communities around the world.
Please check out our products and know that everything you purchase contributes to our cause for Truth, Liberty and Justice for all.
Let just say I had a health scare this past weekend and wound up checking myself into the Emergency room at
Strong Memorial Hospital – Rochester, NY after pain started when I had a hard sneeze. I finished the night at my Walmart security Job and then went on to my 2nd job working at the Rochester City School district as a school sentry. I made it through lunch but I was in to much pain to finish the day that’s when I decided to go see the school nurse and see what she thought. She said that if I was her she would go to the ER thats after she asked me if I was feeling nauseous, up to that point I was in to much pain to think. That until she asked me that question right then it hit me that I was nauseous and that was scary I thought I was having appendix pain after talking to the school nurse and as a safety precaution I decided to go to the ER.
The Next 12 hrs were a real eye opener to me and should be to you as well. So when I first checked myself into the ER it was around 1:30 in the afternoon and they took my info, blood pressure an vitals then told me to wait and that someone would be with me soon and about a 1/2 hr later I was called in to another waiting room inside the ER’s Rapid response hall, were I waited for about 30 minuets till they brought me into the initial examination room that had a table that I sat on and waited for the nurse to take my Vitals again but this time they also took blood as well. After talking to the nurse and residency medical doctor I was asked if I wanted pain medication I made a mistake and said I think I can wait till I talk to the doctor. I must have been put on the not so urgent to see list because I sat in that room for about 3 hrs before my dad showed up and stared to make things happen by asking questions of why its taking so long to see a doctor.
After my dad showed up I was put outside of the Rapid response hallway to wait for a room with other ER patience that took about another 2 hrs sitting in a hallway to wait for a room. Finally they called my name a thought of relief came over me. They took me to a examination room with 6 other people two people per examination area. I thought that this was just another waiting room because it did not have hospital beds just hard plastic chairs for patients to sit in to wait to be examined by the doctors.
As we were waiting to see my doctor the girl that was sitting next to me on her hard plastic chair had her ER doctor came in and proceed to do an examination on this young woman who had to be in her teen to early 20 somethings with out asking us to leave the area. I was still in pain but I decided out of respect for this young woman that I would give her privacy as that’s what Id want for myself or my child. I couldn’t believe that the doctors were going to examine this stranger in front of myself and my dad. All I can say is “Am I in the twilight zone” is this really happening in America. Yes it is an you can thank Obama Care.
This photo above is what you would expect to be placed in when you have a trip to the ER before Obama Care.
This is what you can expect to see in your initial Examination, other people in the ER room with you and a plastic chair. You can for get your rights to privacy and comfort if you voted for Obama.
I have to be thankful that my dad was with me because he spoke up on my behalf and when the doctors came in to examine me for the first time my dad said to the doctors this is ridiculous to be examined in front of other patience s that we didn’t know. He asked about my rights to privacy and about the HIPPA Laws. As soon as my dad asked about the Laws then the doctors quickly left the room and sent in my nurse again, she said that they would get me a room with an examination table and that the residency medical doctor had miss diagnosed me and sent me to the wrong room.
I have to say that this trip to the ER was much different than the 13 other times that I had gone to the ER years ago when I would dislocate my shoulder but that was before this new generation of obamacare. To me it seems that we have taken a step back and have manifested into a 3rd world class of medical care. Years ago you would go to the ER and get first class service yes you would wait just like anyone else but you would get a room asap you wouldn’t get stuck sitting in hard plastic chairs for 6 plus hours sick and in pain. Just to get an examination in front of complete strangers, my dad was correct that is ridiculous and unacceptable. We as the American people should demand better and stop voting for the Communist Socialist Party’s like the Democrats and Republicans that keep moving us closer to a Communist Governmental System or you to can expect to lose your rights and privacy like they tried with me in that examination room.
I have to say all the people at the hospital working were kind and professional to the highest degree expect when it came to the initial examination that they tried to do in front of other strangers. I know how hard these people work because I spent ten years in the Medical field myself and understand the great pressure they are under to preform at such high standards. The problems that I see are coming from the State and the insurance company’s that cover medical treatments. I’m just thankful that my visit to the ER turned out to be just a infection and inflammation that can be treated with antibiotics. So after about 12 hrs I was released to go home and given the weekend off of work and I spent that time recovering and with my baby Girl Ella.
The AntiGMOParty.com is the only political Party to take an stand against food derived from GMO that are harmful to human beings and animal consumption. http://AntiGMOParty.com/
The AntiGMOParty.com was created for consumers. We believe that everyone has the right to an informed choice about what they eat. Many people are concerned about the potential health risks of products made using the relatively new technology of genetic modification (to learn more, please see our About GMOs page). The Non-GMO Project respects your right to know what’s in the food you’re eating and the products you’re buying.
That’s why we have created the world first Political Party for GMO avoidance. The AntiGMOParty.com the only independent, third party, Party that officially has backed a platform to ban GMO Food for human consumption.
By supporting participating members who run for office that are enrolled in the AntiGMOParty, you become an essential part of the collaborative effort to ensure that there are non-GMO choices now and in the future.
Hg (“mercury”) and Pb (“lead”) are every bit as naturally occurring as F (“fluoride”). (Nature also features poppies, cocoa leaves and Belcher’s sea snakes.)
CO₂ (“carbon dioxide”) contains exactly the same elements (namely, C [“carbon”] and O [“oxygen”]) as CO (“carbon monoxide”).
Similarly to the above two molecular compounds, F (“fluoride”) has different chemical properties from NaF (“sodium fluoride”).
NaF (“sodium fluoride”) does not occur in nature but is a waste product of aluminum (a.k.a. aluminium).
One pea-sized dab of fluoride, which if you swallow it you are instructed to contact poison control, is the same amount of fluoride—¼ mg—that we find in 8 oz. of city water.
“Fluoride science is corporate science. It’s DDT science. It’s asbestos science. It’s tobacco science. It’s a racket” (Christopher Bryson).
If we look even further into adjusting fluoride to the drinking water, data shows it has no benefit to the teeth whatsoever. 98% of Europe is completely opposed to having fluoride added to the water supply, versus a great percentage of North America being fluoridated. The dental records in Europe show fewer cavities and tooth decay than what occurs in North America.
Sodium fluoride (NaF), not to be confused with naturally-occurring fluoride (F), is a known neurotoxin, a byproduct of aluminum production, that many public (“city”) water supply systems contain. A Harvard University meta-analysis funded by the National Institutes of Health (NIH) has concluded that children who live in areas with highly fluoridated water have “significantly lower” IQ scores than those who live in low fluoride areas. Currently 90% of water in Great Britain (a.k.a. the United Kingdom) is sodium-fluoride-free.
At the end of World War II, the U.S. Government sent Charles Eliot Perkins, a research worker in chemistry, biochemistry, physiology and pathology, to take charge of the vast Farben chemical plants in Germany. The German chemists told Perkins of a scheme which they had devised during W.W. II and had been adapted by the German General Staff. The German chemists explained of their attempt to control the population in any given area through the mass-medication of drinking water with sodium fluoride, a tactic used in German and Russian prisoner-of-war camps to make the prisoners “stupid and docile” (Stephen, 1995). Farben had developed plans during W.W. II to fluoridate the occupied countries because it was found that fluoridation caused slight damage to a specific part of the brain, making it more difficult for the person affected to defend his freedom and causing the individual to become more docile towards authority. Fluoride remains one of the strongest anti-psychotic substances known, and is contained in twenty-five percent of the major tranquilizers. It may not seem surprising that Hitler’s regime practiced the concept of mind control through chemical means, but the U.S. Military continued Nazi research, exploring techniques to incapacitate an enemy or medicate an entire nation. As stated in the Rockefeller Report, a Presidential briefing on C.I.A. activities, “the drug program was part of a much larger CIA program to study possible means of controlling human behavior” (Stephen 1995).
Fluoridosis has the following cerebral (brain) symptoms:
Reduction in nicotinic acetylcholine receptors
Damage to your hippocampus
Formation of beta-amyloid plaques (the classic brain abnormality in Alzheimer’s disease)
Reduction in lipid content
Damage to purkinje cells
Exacerbation of lesions induced by iodine deficiency
I know a few people who have this but bet they will still not listen to alternative News or idea’s and remain sick or die in pain. Iv seen this happen before why are people so brainwashed by the system that lies all the time? Wake up people and be free from death and pain.
The disease of the digestive tract afflicts 400,000 – 600,000 people in North America alone causing abdominal pain, diarrhea (which can be bloody), severe vomiting, weight loss, as well as secondary skin rashes, arthritis, inflammation of the eye, tiredness, and lack of concentration.
Smoking pot caused a “complete remission” of Crohn’s disease compared to placebo in half the patients who lit up for eight weeks, according to clinical trial data to be published the journal Clinical Gastroenterology and Hepatology.
Researchers at Israel’s Meir Medical Center took 21 people with intractable, severe Crohn’s disease and gave 11 of them two joints a day for eight weeks. “The standardized cannabis cigarettes” contained 23 percent THC and 0.5 percent CBD (cannabidiol). (Such marijuana is available on dispensary shelves in San Francisco, Oakland, and other cities that have regulated access to the drug.) The other ten subjects smoked placebo cigarettes containing no active cannabinoids.
Investigators reported that smoking weed caused a “complete remission” of Crohn’s Disease in five of the 11 subjects. Another five of the eleven test subjects saw their Crohn’s Disease symptoms cut in half. Furthermore, “subjects receiving cannabis reported improved appetite and sleep, with no significant side effects.”
The study is the first placebo-controlled clinical trial to assess the consumption of cannabis for the treatment of Crohn’s, notes NORML. All of the patients had intractable forms of the disease and did not respond to conventional treatments. Still, the United States government claims that marijuana is as dangerous as heroin and has no medical use. U.S. Attorney Melinda Haag is waging a war on safe access to medical cannabis in the Bay Area.
Could it be that the current bed bug infestation is a sign of the End Times? Perhaps a prelude to 2012? Maybe it’s just another thing we can blame Bush or Obama about? Oddly enough, the White House has developed a serious problem of insect infestation ever since Obama moved in.
A good conspiracy theory focuses us Plum Island, New York. A facility there allegedly run by the Department of Agriculture researches animal diseases. However, many believe that it was the site of a Cold War era biological weapon laboratory. Oddly enough, the Army transferred control of Plum Island to the DoA in the early 1950s following an outbreak of foot-and-mouth disease amongst cattle. Since then, some conspiracy experts point to outbreaks of Lyme disease and other bizarre experiments. In the film, “Silence of the Lambs”, the evil Hannibal Lecter called Plum Island “Anthrax Island”.
In 2002, the facility was curiously turned over to control under the Department of Homeland Security. Plum Island was even linked to a potential Al Qaeda terror plot when Aafia Siddiqui, a Pakistani scientist, was arrested in 2008. She was found to have a list of “mass casualty attack” targets, with Plum Island as one of the locations.
Perhaps even more strange is the weird story of the Montauk Monster, started when the carcass of an unidentified creature washed up on shore. Later, the body of a possible human also washed up on shore. The deformed humanoid was said to have a series of five holes drilled into it’s skull, as if part of an experiment. Montauk has also been associated with other conspiracies, ranging from government psychic research to time travel and even inter-dimensional beings. The infamous ‘Montauk Chair’ is said to be part of a U.S. government experiment with alien technology from crashed UFOs.
So what does this have to do with the bed bugs concern? With the current bed bugs infest of homes, apartments, officebuildings and historic hotels like the Waldorf-Astoria? Bed bugs may be part of another experiment gone awry from Plum Island. Perhaps even part of the alleged New World Order plan to reduce the human population to below 500 million people, as depicted on the strange and infamous America’s ‘Stonehenge’, more commonly known as the ‘Georgia Guidestones’. A granite monument which calls for a one-world government and depopulation of the planet of humanity. Are bed bugs, stink bugs and other infestations this year part of such a plan? Who can say?
If you have bed bugs, you can be eaten alive from head to toe. Besides this, there are many psychological effects. Many people are repulsed by people who have bed bugs. This can be extremely humiliating and can subject you to social stigma. Friends can stop visiting and also inviting you to parties. You can be left alone and completely ashamed. It can turn your life completely upside down.
Even in a nice hotel like Vegas, you can be subjected to bed bug bites. This is an infestation problem in the United States, and it can make people feel extremely ashamed. It is similar to the mental disease that can make someone turn into a recluse and a hoarder. It is possible that you simply shouldn’t tell anyone, unless you have the problem taken care of. Honesty may be the best policy, but that will come with a tremendous social cost. Even people at your work will want to stay away from you because they will not want to come near you.
If you stay in a hotel, you should avoid placing your luggage on the bed.
Anti Deep State Party 